France· FR:68071018
ALPROLIX 1000 UI, poudre et solvant pour solution injectable
A eftrenonacog alfa product containing eftrénonacog alfa, registered in France by SWEDISH ORPHAN BIOVITRUM (SUEDE). The same ATC class is registered in 3 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Eftrenonacog alfa is registered in 3 of 19 countries.
Countries holding a registration under ATC B02BD34 (eftrenonacog alfa), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 2 of them publish a price we can compare per daily dose
Eftrenonacog alfa · ATC B02BD34
3 / 19 countries
- Franceprice
- Italyprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- EFTRÉNONACOG ALFA
- Manufacturer
- SWEDISH ORPHAN BIOVITRUM (SUEDE)
- Country
- France (FR)
- ATC code
- B02BD34
- ATC class
- Eftrenonacog alfa
- Defined daily dose
- 400 E, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550228551 Boite de 1 flacon de 1000 UI (en verre) + 1 seringue préremplie de 5 ml (200 UI/mL) + 1 piston de seringue + 1 adaptateur pour flacon + 1 kit de perfusion + 2 tampons alcoolisés + 2 pansements + 1 compresse de gaze
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eftrenonacog alfa in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAlprolix 1000 IU, poeder en oplosmiddel voor oplossing voor injectieSwedish Orphan Biovitrum AB (publ)
- Japanエフトレノナコグ アルファ（遺伝子組換え）サノフィ
- SwitzerlandAlprolix
- CzechiaALPROLIXSwedish Orphan Biovitrum AB (publ), Stockholm
- SpainALPROLIX 1.000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLESwedish Orphan Biovitrum Ab (Publ)
- FinlandALPROLIXSwedish Orphan Biovitrum AB (publ)
- SwedenALPROLIX 1000 IE Pulver och vätska till injektionsvätska, lösningSwedish Orphan Biovitrum AB (publ)
- PolandAlprolixSwedish Orphan Biovitrum AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Alprolix
- Liechtenstein · Alprolix
- Norway · Alprolix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5597d98e-a750-4aa0-8aa6-426cc07628f7 GET /v1/drugs/5597d98e-a750-4aa0-8aa6-426cc07628f7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68071018",
"date_amm": "2016-05-12",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/16/1098",
"substance": "EFTRÉNONACOG ALFA",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about eftrenonacog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.